Lisanne C. Hamming
Leeuwarden, FR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Author Correction: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer.
Journal: Nature
Published: July 22, 2025
Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial.
Journal: Journal of the National Cancer Institute
Published: June 20, 2025
Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial.
Journal: Journal of the National Cancer Institute
Published: June 20, 2025
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial.
Journal: Nature medicine
Published: February 24, 2025
Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial.
Journal: EClinicalMedicine
Published: September 05, 2024
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer.
Journal: Nature
Published: January 09, 2024
Myelopathy in systemic lupus erythematosus: a case report and a review of the literature.
Journal: The Netherlands journal of medicine
Published: August 01, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026